Results 291 to 300 of about 382,720 (316)

Mechanism of alternative complement pathway dysregulation by a phosphorothioate oligonucleotide in monkey and human serum.

Nucleic Acid Therapeutics, 2014
The species sensitivity and mechanism of complement pathway activation by a phosphorothioate oligonucleotide were investigated in monkey and human serum. Increasing concentrations of a phosphorothioate oligonucleotide, ISIS 2302, were incubated in either
Scott P. Henry, M. Jagels, Tony E. Hugli, Sheri Manalili, Richard S. Geary, Patricia C. Giclas, Arthur A. Levin   +6 more
semanticscholar   +1 more source

Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration.

Investigative Ophthalmology and Visual Science, 2012
PURPOSE To determine if the progression of age-related macular degeneration (AMD) is associated with complement activation in the eye. METHODS Immunohistochemistry and ELISAs were used to determine the distribution, concentration, and activation of the
K. Loyet, L. Deforge, K. Katschke, L. Diehl, R. Graham, L. Pao, L. Sturgeon, Sock-Cheng Lewin-Koh, J. Hollyfield, M. van Lookeren Campagne   +9 more
semanticscholar   +1 more source

Faculty Opinions recommendation of Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2020
Richard Smith
semanticscholar   +1 more source

Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis

Clinical Rheumatology, 2020
J. Mejía-Vilet, I. Gómez-Ruiz, C. Cruz, R. A. Méndez-Pérez, Roque A. Comunidad-Bonilla, N. Uribe-Uribe, C. Núñez-Álvarez, L. Morales-Buenrostro   +7 more
semanticscholar   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Paulo Cáceres Guido, Jun J Mao, Lorenzo Cohen   +2 more
exaly  

Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy

Pediatric nephrology (Berlin, West), 2018
M. Noris, R. Donadelli, G. Remuzzi
semanticscholar   +1 more source

A systematic review of rehabilitation and exercise recommendations in oncology guidelines

Ca-A Cancer Journal for Clinicians, 2021
Kathleen Doyle Lyons, Nicole L Stout, Daniel Santa Mina   +2 more
exaly  

Intermittent fasting in the prevention and treatment of cancer

Ca-A Cancer Journal for Clinicians, 2021
Katherine Clifton, Luigi Fontana, Lindsay L Peterson   +2 more
exaly  

Small-molecule factor D inhibitors targeting the alternative complement pathway.

Nature Chemical Biology, 2016
J. Maibaum, S. Liao, A. Vulpetti, N. Ostermann, S. Randl, S. Rüdisser, E. Lorthiois, P. Erbel, B. Kinzel, F. Kolb, S. Barbieri, J. Wagner, Corinne Durand, Kamal Fettis, Solene Dussauge, N. Hughes, Omar Delgado, U. Hommel, T. Gould, A. Mac Sweeney, B. Gerhartz, F. Cumin, S. Flohr, A. Schubart, B. Jaffee, R. Harrison, A. Risitano, J. Eder, K. Anderson   +28 more
semanticscholar   +1 more source

Spirituality and religion in oncology

Ca-A Cancer Journal for Clinicians, 2013
John R Peteet
exaly